Scarab Genomics
Biotechnology, 1202 Ann St, Madison, Wisconsin, 53713, United States, 11-50 Employees
Phone Number: 60********
Who is SCARAB GENOMICS
Scarab Genomics, an emerging CMO, has created Clean Genome E. coli, a unique, patented set of bacterial hosts for reliable, high efficiency production of protein and nucleic acid biopharm...
Read More
- Headquarters: 1202 Ann St, Madison, Wisconsin, 53713, United States
- Date Founded: 2002
- Employees: 11-50
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Frederick Blattner
Industry: Biotechnology
SIC Code: 2834 | NAICS Code: 561110 | Show More
Does something look wrong? Fix it. | View contact records from SCARAB GENOMICS
Scarab Genomics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Scarab Genomics
Answer: Scarab Genomics's headquarters are located at 1202 Ann St, Madison, Wisconsin, 53713, United States
Answer: Scarab Genomics's phone number is 60********
Answer: Scarab Genomics's official website is https://scarabgenomics.com
Answer: Scarab Genomics's revenue is $1 Million to $5 Million
Answer: Scarab Genomics's SIC: 2834
Answer: Scarab Genomics's NAICS: 561110
Answer: Scarab Genomics has 11-50 employees
Answer: Scarab Genomics is in Biotechnology
Answer: Scarab Genomics contact info: Phone number: 60******** Website: https://scarabgenomics.com
Answer: Scarab Genomics, an emerging CMO, has created Clean Genome E. coli, a unique, patented set of bacterial hosts for reliable, high efficiency production of protein and nucleic acid biopharmaceuticals. All troublesome genetic elements, inlcuding IS elements and cryptic phages, and many nonessential genes, have been removed from the genome, resulting in more efficient and more reliable production. Benefits include reduced mutational damage to vectors and products, elimination of contamination of nucleic acid vaccines with IS elements, and prevention of loss of fermentation batches due to phage induction. Current licensees use these hosts for production of proteins and DNA vaccines. Clean Genome E. coli is, unlike other hosts, capable of continuous production, which has been implemented as C-FlowTM. A typical 30-day C-FlowTM process yields 4.5 kg protein per month before purification at a mere 10-liter scale, dramatically reducing infrastructure requirements for substantial production volumes. Because production is continuous, conditions can be optimized on the fly, and because volumes are small, scale-up is rapid. As a result process development is rapid, enabling quick responses to pandemics such as Covid-19 and to bioterrorism. At even 1-L scale C-FlowTM can efficiently address needs for orphan drugs and personalized medicine. Enabled by reduced genome strains, we sell research grade vaccine carrier proteins CRM197 and Protein D, and are developing continuous cGMP manufacturing of CRM197 for clinical needs. Scarab offers licensing options for research and for commercial production. Clients may license Clean Genome strains customized for specific applications using their existing production infrastructure, or the full C-FlowTM continuous fermentation system for maximum efficiency.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month